Committee Advice Documents
On this page
Skip the menu of subheadings on this page.Committee Advice documents summarise the advice the Committee has provided for the GM and novel foods regulated products applications where their advice was sought. They outline the areas they were asked to advise on and the conclusions reached, based on the evidence presented. These are used by the Food Standards Agency (FSA) and Food Standards Scotland (FSS) to inform the development of Safety Assessments which addresses the requirement in the legislation for an Opinion.
The completed Committee Advice Documents can be found below:
Schizochytrium sp. oil rich in DHA and EPA - RP 1411
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Schizochytrium sp. oil rich in DHA and EPA
Isomalto-oligosaccharides - RP1033
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Change of conditions of use for the novel food, isomalto-oligosaccharides
Magnesium L-threonate - RP956
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Magnesium L-threonate as a novel food for use in food supplements
Barley Rice Protein - RP19
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Cetylated Fatty Acids - RP200
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
3-fucosyllactose (3-FL) - RP1202
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
3-fucosyllactose (3-FL) - RP1202
Lacto-N-fucopentaose I (LNFP-I) and 2'-fucosyllactose (2'-FL) - RP549
This Committee Advice Document outlines the conclusions reached on the areas of the regulated product assessment where the Committee were asked to review. These are used to inform the FSA/FSS Safety Assessment for the application.
Lacto-N-fucopentaose I (LNFP-l) and 2'-fucosyllactose (2'-FL) - RP549